Plaque Psoriasis Clinical Study
We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.
We are seeking patients that meet the below criteria to participate in a study to evaluate the safety and efficacy of Cedirogant (oral tablet) versus placebo in adult subjects with moderate to severe psoriasis.
- Males and females ages 18-65
- History of plaque psoriasis in the past 6 months
- Must have psoriasis involvement of 10% or greater of body surface area (1% is approximately equivalent to the size of your palm)
- Be available for 8 office visits over a 16-week treatment period, and a one phone call during the 30-day follow-up period
If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.